InVision logo

InVision

California, United States Healthcare Technology Out of Business

InVision Medical Technology is a Y Combinator-backed medical AI company building clinically-validated, FDA-cleared software for echocardiography, the world's most common cardiac imaging exam. Its Precision LVEF and Precision Cardiac Amyloid products analyze standard DICOM ultrasound studies to standardize measurements and surface underdiagnosed disease. It is founded by the Stanford and Cedars-Sinai researchers who authored the first prospective randomized clinical trial of AI in cardiology (published in Nature).

Out of Business

InVision is no longer in operation

December 31, 2024

This company is no longer available on our private secondary market.

Overview

Company data and valuation marks are estimates and may be incomplete, stale, erroneous, or revised.

Founded

2011

Employees

11–50

Total Funding

$500K

6 rounds

Latest Valuation

$1.9B

December 11, 2018

Funding

Total raised $500K across 6 rounds

Funding data and valuation marks are estimates and may be incomplete, stale, erroneous, or revised.

Last updated 06-10-2026

Latest Round

Type

Series F

Date

December 11, 2018

Amount

$115M

Valuation

$1.9B

Lead Investors

Spark Capital
DateRoundAmount RaisedValuationLead Investors
December 11, 2018 Series F $115M $1.9B Spark Capital
November 1, 2017 Series E $100M $1B Battery Ventures
June 21, 2016 Series D $55M ICONIQ Capital

Funding by Round

Funding data and valuation marks are estimates and may be incomplete, stale, erroneous, or revised.

Valuation Trajectory

Valuation indexed to 1.0× at the selected entry round. Valuation marks are estimates and may contain errors. Hover each dot to compare.

If you invested at:
1x 2x 2018 InVision

Entry · Series E

$1B

Nov 2017

InVision today

$1.9B

Dec 2018 · latest mark

InVision multiple

1.9x

valuation uplift since first round

Y-axis is logarithmic. Hollow dots = estimated valuations. Does not represent realized investor returns.

Prominent Investors

Spark Capital Goldman Sachs Battery Ventures ICONIQ Growth Firstmark Capital Geodesic Capital Atlassian Ventures Atlassian Tiger Global Management Battery Ventures First Mark Capital ICONIQ Growth Spark Capital Goldman Sachs Geodesic Capital

Leadership

  • David Ouyang

    Co-founder & CEO

Competitors

Competitor list is illustrative and may be incomplete, stale, or erroneous.

  • Figma

    Real-time collaborative design platform offering UI design, prototyping, and design system management in a browser-based interface

  • Adobe XD

    Vector-based design tool for UI/UX creation with integration to Adobe Creative Cloud and real-time collaboration features

  • Miro

    Innovation workspace and whiteboard platform acquired InVision's Freehand product; supports design, ideation, and team collaboration

  • Penpot

    Open-source design and prototyping platform providing free collaborative design tools

Access live market data

Sign Up

Data collected with AI, which can make mistakes. Please double-check this information.